Research output per year
Research output per year
- 12 results
Search results
-
2022
Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies
Ghobadi, A., Landmann, J. H., Carter, A., Cooper, M. L., Selli, M. E., Chang, J., Baker, M., Miller, C. A., Ferraro, F., Chen, D. Y., Smith, A. M., LaValle, T. A., Duncavage, E. J., Chou, J., Tam, V., Benoun, J. M., Nater, J., Scholler, N., Milletti, F. & Vezan, R. & 3 others, , Oct 25 2022, In: Blood Advances. 6, 20, p. 5634-5640 7 p.Research output: Contribution to journal › Letter › peer-review
Open Access2 Scopus citations -
DNMT3A overgrowth syndrome is associated with the development of hematopoietic malignancies in children and young adults
Ferris, M. A., Smith, A. M., Heath, S. E., Duncavage, E. J., Oberley, M., Freyer, D., Wynn, R., Douzgou, S., Maris, J. M., Reilly, A. F., Wu, M. D., Choo, F., Fiets, R. B., Koene, S., Spencer, D. H., Miller, C. A., Shinawi, M. & Ley, T. J., Jan 20 2022, In: Blood. 139, 3, p. 461-464 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access14 Scopus citations -
Tumor suppressor function of WT1 in acute promyelocytic leukemia
Christopher, M. J., Katerndahl, C. D. S., LeBlanc, H. R., Elmendorf, T. T., Basu, V., Gang, M., Menssen, A. J., Spencer, D. H., Duncavage, E. J., Ketkar, S., Wartman, L. D., Ramakrishnan, S. M., Miller, C. A. & Ley, T. J., Jan 2022, In: Haematologica. 107, 1, p. 342-346 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access6 Scopus citations -
2021
Genome sequencing in myeloid cancers
Duncavage, E., Schroeder, M. & Spencer, D. H., Jun 24 2021, In: New England Journal of Medicine. 384, 25, e106.Research output: Contribution to journal › Letter › peer-review
8 Scopus citations -
2019
Exome analysis of treatment-related AML after APL suggests secondary evolution
Wang, T., Jacoby, M. A., Duncavage, E. J., Miller, C. A., Heath, S., Rahme, R., Fenaux, P., Ades, L., Renneville, A., Cassinat, B., Takeshita, A., Asou, N., Miyazaki, Y., Kiyoi, H., Ravandi, F., Westervelt, P., Wartman, L. D. & Welch, J. S., Jun 2019, In: British Journal of Haematology. 185, 5, p. 984-987 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignancies
Ruzinova, M. B., Lee, Y. S., Duncavage, E. J. & Welch, J. S., Jul 31 2019, In: Haematologica. 104, 8, p. e345-e348Research output: Contribution to journal › Letter › peer-review
Open Access22 Scopus citations -
2018
Authors' Reply
Li, M. M., Datto, M., Duncavage, E. J., Kulkarni, S., Lindeman, N. I., Roy, S., Tsimberidou, A. M., Vnencak-Jones, C. L., Wolff, D. J., Younes, A. & Nikiforova, M. N., Jan 2018, In: Journal of Molecular Diagnostics. 20, 1, p. 125-126 2 p.Research output: Contribution to journal › Letter › peer-review
Open Access2 Scopus citations -
Loss of Toll-like receptor 2 results in accelerated leukemogenesis in the NUP98-HOXD13 mouse model of MDS
Monlish, D. A., Bhatt, S. T., Duncavage, E. J., Greenberg, Z. J., Keller, J. L., Romine, M. P., Yang, W., Aplan, P. D., Walter, M. J. & Schuettpelz, L. G., Mar 1 2018, In: Blood. 131, 9, p. 1032-1035 4 p.Research output: Contribution to journal › Letter › peer-review
Open Access12 Scopus citations -
2017
Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy
Duncavage, E. J., Uy, G. L., Petti, A. A., Miller, C. A., Lee, Y. S., Tandon, B., Gao, F., Fronick, C. C., O'Laughlin, M., Fulton, R. S., Wilson, R. K., Jacoby, M. A., Cashen, A. F., Wartman, L. D., Walter, M. J., Westervelt, P., Link, D. C., DiPersio, J. F., Ley, T. J. & Welch, J. S., Mar 9 2017, In: Blood. 129, 10, p. 1397-1401 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access25 Scopus citations -
2016
A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML
Krysiak, K., Christopher, M. J., Skidmore, Z. L., Demeter, R. T., Magrini, V., Kunisaki, J., O'Laughlin, M., Duncavage, E. J., Miller, C. A., Ozenberger, B. A., Griffith, M., Wartman, L. D. & Griffith, O. L., Apr 8 2016, In: Blood cancer journal. 6, e413.Research output: Contribution to journal › Letter › peer-review
Open Access13 Scopus citations -
Targeted sequencing informs the evaluation of normal karyotype cytopenic patients for low-grade myelodysplastic syndrome
Duncavage, E. J., O'Brien, J., Vij, K., Miller, C. A., Chang, G. S., Shao, J., Jacoby, M. A., Heath, S., Janke, M. R., Elliott, K., Fulton, R. S., Fronick, C., O'Laughlin, M., Westervelt, P., Ley, T. J., Wilson, R. K. & Walter, M. J., Dec 1 2016, In: Leukemia. 30, 12, p. 2422-2426 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access5 Scopus citations -
2010
Limited engraftment of low-risk myelodysplastic syndrome cells in NOD/SCID gamma-C chain knockout mice
Martin, M. G., Welch, J. S., Uy, G. L., Fehniger, T. A., Kulkarni, S., Duncavage, E. J. & Walter, M. J., Sep 2010, In: Leukemia. 24, 9, p. 1662-1664 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access25 Scopus citations